Evidence map›Paper›PMID 42056459›Full record

ArticleInternal and emergency medicine2026

Closed-loop protocol for inferior vena cava filter management significantly improves retrieval: a competing-risk analysis of a 10-year cohort.

Víctor Manuel Martínez-Castilla, Elena Rodríguez-Llamas, Ana de-Miguel-Álvarez, Marina López-Rubio, Marta Olimpia Lago-Rodríguez, Rubén Alonso-Beato, Arturo Álvarez-Luque, Enrique Calleja-Cartón, Lucía Ordieres-Ortega, Sergio Moragón-Ledesma and 3 more

Abstract read
In one paragraph

Article in Internal and emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Víctor Manuel Martínez-CastillaVenous Thromboembolism Unit. Internal Medicine Department. Hospital General, Universitario Gregorio Marañón, C/. Doctor Esquerdo, 46, 28007, Madrid, Spain.
Elena Rodríguez-LlamasVenous Thromboembolism Unit. Internal Medicine Department. Hospital General, Universitario Gregorio Marañón, C/. Doctor Esquerdo, 46, 28007, Madrid, Spain.
Ana de-Miguel-ÁlvarezVenous Thromboembolism Unit. Internal Medicine Department. Hospital General, Universitario Gregorio Marañón, C/. Doctor Esquerdo, 46, 28007, Madrid, Spain.
Marina López-RubioVenous Thromboembolism Unit. Internal Medicine Department. Hospital General, Universitario Gregorio Marañón, C/. Doctor Esquerdo, 46, 28007, Madrid, Spain.
Marta Olimpia Lago-RodríguezVenous Thromboembolism Unit. Internal Medicine Department. Hospital General, Universitario Gregorio Marañón, C/. Doctor Esquerdo, 46, 28007, Madrid, Spain.
Rubén Alonso-BeatoVenous Thromboembolism Unit. Internal Medicine Department. Hospital General, Universitario Gregorio Marañón, C/. Doctor Esquerdo, 46, 28007, Madrid, Spain.
Arturo Álvarez-LuqueSanitary Research Institute Gregorio Marañón, Madrid, Spain.
Enrique Calleja-CartónSanitary Research Institute Gregorio Marañón, Madrid, Spain.
Lucía Ordieres-OrtegaVenous Thromboembolism Unit. Internal Medicine Department. Hospital General, Universitario Gregorio Marañón, C/. Doctor Esquerdo, 46, 28007, Madrid, Spain.
Sergio Moragón-LedesmaVenous Thromboembolism Unit. Internal Medicine Department. Hospital General, Universitario Gregorio Marañón, C/. Doctor Esquerdo, 46, 28007, Madrid, Spain.
Pablo Demelo-RodríguezVenous Thromboembolism Unit. Internal Medicine Department. Hospital General, Universitario Gregorio Marañón, C/. Doctor Esquerdo, 46, 28007, Madrid, Spain.
Luis A Alvarez-Sala-WaltherVenous Thromboembolism Unit. Internal Medicine Department. Hospital General, Universitario Gregorio Marañón, C/. Doctor Esquerdo, 46, 28007, Madrid, Spain.
Francisco Galeano-ValleVenous Thromboembolism Unit. Internal Medicine Department. Hospital General, Universitario Gregorio Marañón, C/. Doctor Esquerdo, 46, 28007, Madrid, Spain. paco.galeano.valle@gmail.com.ORCID http://orcid.org/0000-0003-1321-6866

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inferior vena cava (IVC) filters are indicated only in acute venous thromboembolism (VTE) with an absolute contraindication to anticoagulation and should be retrieved once anticoagulation can be resumed. However, real-world retrieval rates remain low and highly variable. The objective is to assess whether implementing an institutional protocol improved appropriateness of IVC-filter placement and retrieval rates at 90 and 180 days, and to evaluate safety outcomes. Retrospective pre-post single-center study including adults who received an IVC filter between January 2015 and July 2025. Co-primary outcomes were appropriateness at placement (acute VTE ≤ 30 days plus absolute contraindication to anticoagulation) and retrieval, evaluated at 90 and 180 days using Fine-Gray competing-risk models. Among 234 patients (pre n = 182; post n = 52), cancer prevalence was similar (40.1% vs 38.5%). Appropriateness increased from 74.7% to 88.5% (risk ratio 1.18, 95% CI 1.04-1.35; p = 0.036). Retrieval improved at day 90 (41.2% → 65.4%, p = 0.020) and at day 180 (41.8% → 73.1%, p < 0.001). In Fine-Gray models, the post-protocol period was associated with a higher cumulative incidence of retrieval (adjusted sub-HR 1.68 [1.16-2.43] at 90 days; 1.92 [1.39-2.66] at 180 days), consistent with cause-specific Cox estimates. Procedure-related complications did not increase. Although overall mortality was unchanged, retrieval was independently associated with lower 180 days (adjusted HR 0.20 [0.08-0.48]). Implementing a closed-loop, guideline-aligned protocol improved appropriateness and substantially increased IVC-filter retrieval without compromising safety. Older age and active cancer remained barriers to retrieval, highlighting priority groups for targeted follow-up strategies.

Indexed as

Device RemovalVena Cava FiltersAdultAgedAnticoagulantsCohort StudiesFemaleHumansMaleMiddle AgedRetrospective StudiesRisk AssessmentVenous ThromboembolismAnticoagulantsAnticoagulationBleeding riskDeep venous thrombosisInferior vena cava filtersPulmonary embolism

Identifiers

PMID42056459
PMCPMC13452834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.